Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: FutTheWuk, Hope that serves to ennervate your synapses

Jan 17, 2008 04:42PM
33
Jan 17, 2008 06:22PM
1
Jan 17, 2008 09:51PM
4
Jan 18, 2008 02:41AM

Jan 18, 2008 06:06AM
23
Jan 18, 2008 06:27AM

Jan 18, 2008 06:59AM

Jan 18, 2008 07:12AM
3
Jan 18, 2008 07:19AM
2
Jan 18, 2008 09:41AM
1
Jan 18, 2008 09:59AM
2
Jan 18, 2008 10:02AM

Jan 18, 2008 10:46AM
8
Jan 18, 2008 07:26PM
1
Jan 19, 2008 05:58AM
16
Jan 19, 2008 07:06AM
11
Jan 19, 2008 11:21AM

Re: FutTheWuk, Hope that serves to ennervate your synapses

in response to by
posted on Jan 19, 2008 01:30PM

Well, not quite.

You addressed the possible M&A issues from your perspective yet failed to acknowledge that PTSC has done what you say it shouldn't: the Chinese partnership and the company that fell through on price.

 

Discussions in October and November of 2006 with a privately held company that was a merger candidate broke down over the issue of valuation. There are informal indications the other company may want to rekindle discussions

 

Also, what originally appeared to be promising discussions regarding a potential joint venture in China regarding the Ignite chip have dried up. Although there currently is no ongoing R&D regarding the Ignite chip, consideration is being given, among other things, to a feasibility review of the company's patent on ground penetrating radar technology and the possibility of combining it with more recent technology plus perhaps the Ignite chip.

http://www.ptsc.com/news/press_releases/2007notes.asp

 

 

As can be seen, just from the above, there is far more that could have been discussed without mentioning either licensing or M&A. An update on any ideas for the other "umbrella ribs" could also have been given.

 

 

Be well


Jan 19, 2008 02:31PM
1
Jan 20, 2008 02:23PM

Jan 21, 2008 05:11AM
3
Jan 21, 2008 06:33AM
Share
New Message
Please login to post a reply